China plănuieşte deja să întărească vaccinarea anti-Covid a populaţiei, imunizată majoritar cu antigeni de fabricaţie locală din virus inactivat, cu o doză adiţională a vaccinului cu ARN mesager ...

Pfizer will pay Chinese drugmaker YaoPharma $150 million for rights to an experimental obesity pill as the company works to catch up in a market dominated by Eli Lilly and Novo Nordisk. The deal, ...

Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges ...

Pfizer on Tuesday joined the cavalcade of big pharma firms hunting for novel weight loss drugs in the laboratories of Chinese biotechs, even as U.S. authorities ramp up efforts to undercut the growing ...

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Advances Migraine Prevention Study in China The phase 3 study, officially titled “A Phase 3, Randomized, Double-Blind, ...

Yao Pharma's deal with the US pharmaceutical giant underscores China's growing role in global biotech licensing US pharmaceutical behemoth Pfizer has agreed to pay up to US$2.1 billion to ...

Pfizer today announced a partnership with Fudan University to establish a graduate program in Clinical Data Management and Statistical Programming. This three year Masters Degree program, a first of ...